Hm Payson & CO Becton Dickinson & CO Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Hm Payson & CO holds 52,184 shares of BDX stock, worth $11.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

52,184

Previous 54,877 4.91%

Holding current value

$11.7 Million

Previous $12.8 Million 1.9%

% of portfolio

0.22%

Previous 0.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$221.47 - $242.41 $596,418 - $652,810	-2,693 Reduced 4.91%	52,184 $12.6 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $348,183 - $380,824	-1,547 Reduced 2.74%	54,877 $12.8 Million
Q1 2024 Jun 20, 2024	SELL	$233.45 - $247.73 $310,488 - $329,480	-1,330 Reduced 2.3%	56,424 $14 Million
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $248,264 - $285,668	1,069 Added 1.89%	57,754 $14.1 Million
Q3 2023 Nov 06, 2023	SELL	$254.9 - $283.59 $310,213 - $345,129	-1,217 Reduced 2.1%	56,685 $14.7 Million
Q2 2023 Jul 17, 2023	SELL	$238.39 - $265.32 $265,566 - $295,566	-1,114 Reduced 1.89%	57,902 $15.3 Million
Q1 2023 Apr 18, 2023	SELL	$229.71 - $259.35 $99,923 - $112,817	-435 Reduced 0.73%	59,016 $14.6 Million
Q4 2022 Feb 06, 2023	SELL	$218.29 - $256.91 $65,923 - $77,586	-302 Reduced 0.51%	59,451 $15.1 Million
Q3 2022 Oct 25, 2022	SELL	$51.03 - $264.23 $98,487 - $509,963	-1,930 Reduced 3.13%	59,753 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $248,120 - $291,118	-1,057 Reduced 1.68%	61,683 $15.2 Million
Q1 2022 May 12, 2022	SELL	$243.64 - $270.48 $460,723 - $511,477	-1,891 Reduced 2.93%	62,740 $16.7 Million
Q4 2021 Feb 15, 2022	SELL	$230.08 - $250.94 $705,195 - $769,131	-3,065 Reduced 4.53%	64,631 $16.3 Million
Q3 2021 Nov 30, 2021	SELL	$232.72 - $256.47 $37,700 - $41,548	-162 Reduced 0.24%	67,696 $16.6 Million
Q2 2021 Aug 17, 2021	SELL	$232.65 - $254.58 $519,274 - $568,222	-2,232 Reduced 3.18%	67,858 $16.5 Million
Q1 2021 Jun 15, 2021	SELL	$232.09 - $256.88 $159,213 - $176,219	-686 Reduced 0.97%	70,090 $17 Million
Q4 2020 Mar 10, 2021	SELL	$221.92 - $245.94 $251,879 - $279,141	-1,135 Reduced 1.58%	70,776 $17.7 Million
Q3 2020 Dec 21, 2020	SELL	$215.77 - $276.76 $321,928 - $412,925	-1,492 Reduced 2.03%	71,911 $16.7 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $182,517 - $218,630	-830 Reduced 1.12%	73,403 $17.6 Million
Q1 2020 Jul 01, 2020	SELL	$195.69 - $279.01 $168,293 - $239,948	-860 Reduced 1.15%	74,233 $17.1 Million
Q4 2019 Feb 18, 2020	SELL	$236.45 - $266.82 $51,073 - $57,633	-216 Reduced 0.29%	75,093 $20.4 Million
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $256,866 - $285,273	1,114 Added 1.5%	75,309 $19.1 Million
Q2 2019 Aug 15, 2019	SELL	$217.4 - $246.08 $453,061 - $512,830	-2,084 Reduced 2.73%	74,195 $18.7 Million
Q1 2019 Jul 31, 2019	BUY	$206.05 - $248.17 $15.7 Million - $18.9 Million	76,279 New	76,279 $19 Million
Q4 2018 Feb 15, 2019	SELL	$204.73 - $257.93 $13.4 Million - $16.9 Million	-65,605 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$233.07 - $256.0 $1.63 Million - $1.79 Million	-7,011 Reduced 9.65%	65,605 $17.1 Million
Q2 2018 Aug 27, 2018	SELL	$208.1 - $233.85 $127,981 - $143,817	-615 Reduced 0.84%	72,616 $17.4 Million
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $42,530 - $49,735	-207 Reduced 0.28%	73,231 $15.9 Million
Q4 2017 Feb 16, 2018	SELL	$189.0 - $222.64 $53,676 - $63,229	-284 Reduced 0.39%	73,438 $15.7 Million
Q3 2017 Nov 06, 2017	BUY	$186.89 - $198.9 $13.8 Million - $14.7 Million	73,722	73,722 $14.4 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account